This is a preview of subscription content, log in via an institution to check access.
Reference
Scholz S, et al. The cost-of-illness for invasive meningococcal disease caused by serogroup B Neisseria meningitidis (MenB) in Germany. Vaccine : 18 Jan 2019. Available from: URL: http://dx.doi.org/10.1016/j.vaccine.2019.01.013
Rights and permissions
About this article
Cite this article
Considerable economic burden of MenB in Germany. PharmacoEcon Outcomes News 821, 11 (2019). https://doi.org/10.1007/s40274-019-5628-9
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40274-019-5628-9